logo
Plus   Neg
Share
Email

Elanco To Acquire Animal Health Division Of Bayer In $7.6 Bln Deal - Quick Facts

Elanco (ELAN), a global animal health company, has agreed to acquire the animal health division of Bayer AG (BAYN). The total deal is valued at $7.6 billion with a 70 percent to 30 percent cash-to-equity mix. Bayer AG will receive $5.32 billion in cash, and $2.28 billion or approximately 68 million Elanco Animal Health shares. The deal is anticipated to close in mid-2020.

Elanco expects the acquisition to provide adjusted EPS accretion in the first full year post-closing, and then high single to low double-digit percentage accretion in year two.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT